Indication
Thrombolytic therapy of acute myocardial infarction
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Myocardial Infarction
Marketing Authorisation Holder: Roche Registration Ltd.
EMA Authorisation: 29/08/1996
INN: reteplase
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ecokinase: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.